Table 3.
Comparison of autophagy and lysosomal markers in male and female placentas from normal weight women and women with increased adiposity (OW and OB).
| Males |
Females |
|||
|---|---|---|---|---|
| NW | Increased adiposity | NW | Increased adiposity | |
| Markers for activation of autophagy: | ||||
| Ratio p-AMPK:t-AMPK | – | ↑ vs. NW | – | – |
| MTOR signaling | – | – | – | – |
| C20 ceramide | – | ↑ vs. NW | ↑ vs. male | – |
| C16/C18 dihydroceramides | – | ↑ vs. NW | ↑ vs. male | – |
| Autophagy markers: | ||||
| ATG3 | – | – | – | ↑ vs. NW |
| ATG7 | – | ↑ vs. NW | – | – |
| BECN1 | – | ↑ vs. NW | ↑ vs. male | – |
| Ratio MAP1LC3B-II:MAP1LC3B-I | – | ↑ vs. NW | ↑ vs. male | – |
| SQSTM1/p62 | – | ↑ vs. NW | – | – |
| Markers for autophagosome-lysosome fusion: | ||||
| STX17-SNAP29-VAMP8 | – | ↑ vs. NW | ↑ vs. male | – |
| Markers for autolysosomes: | ||||
| TFEB | – | ↓ vs. NW | – | – |
| CTSB | – | – | – | – |
| LAMP2 | – | – | – | ↑ vs. NW |